Goodwill and Other Intangible Assets

3 Months Ended

Jan. 31, 2018

Goodwill And Intangible Assets Disclosure [Abstract]

5.	Goodwill and other intangible assets

Changes in the carrying amount of goodwill for the three months ended January 31, 2018 by operating segment are as follows:

	Adhesive Dispensing Systems		Advanced Technology Systems		Industrial Coating Systems		Total
Balance at October 31, 2017	$	392,295	$	1,172,857	$	24,058	$	1,589,210
Acquisition		—		20,078		—		20,078
Currency effect		7,561		5,276		—		12,837
Balance at January 31, 2018	$	399,856	$	1,198,211	$	24,058	$	1,622,125

Accumulated impairment losses, which were recorded in 2009, were $232,789 at January 31, 2018 and October 31, 2017. Of these losses, $229,173 related to the Advanced Technology Systems segment, and $3,616 related to the Industrial Coating Systems segment.

Information regarding our intangible assets subject to amortization is as follows:

	January 31, 2018
	Carrying Amount		Accumulated Amortization		Net Book Value
Customer relationships	$	487,946	$	113,320	$	374,626
Patent/technology costs		156,919		52,741		104,178
Trade name		97,322		30,215		67,107
Non-compete agreements		11,732		9,657		2,075
Other		1,393		1,392		1
Total	$	755,312	$	207,325	$	547,987

	October 31, 2017
	Carrying Amount		Accumulated Amortization		Net Book Value
Customer relationships	$	480,536	$	102,033	$	378,503
Patent/technology costs		150,581		48,669		101,912
Trade name		93,281		28,366		64,915
Non-compete agreements		11,142		9,298		1,844
Other		1,384		1,378		6
Total	$	736,924	$	189,744	$	547,180

Amortization expense for the three months ended January 31, 2018 and 2017 was $13,889 and $7,630, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details